The advertised “Ozempic for $25” comes from the manufacturer savings card (Novo Nordisk). To qualify you need commercial insurance — through an employer or the ACA marketplace — that already covers Ozempic, plus a prescription for type 2 diabetes (its FDA-approved use). The card then reduces your copay to as little as $25 for a 1-month supply, with maximum savings of $100 per 1-month, $200 per 2-month, or $300 per 3-month fill.
Federal anti-kickback rules exclude government insurance: the card cannot be used with Medicare, Medicaid, VA or TRICARE. It also does not help if you are uninsured — there is currently no $25 cash route for brand Ozempic. Enroll on the official Ozempic savings page (ozempic.com) or by phone at 1-877-304-6855; pharmacies apply it like a secondary payer at the counter.
If you are uninsured or your plan excludes Ozempic, NovoCare self-pay applies instead of the card: $199 for each of the first two pen fills, then $349/month at 0.25, 0.5 or 1 mg and $499 at 2 mg; Ozempic tablets start at $149. Compounded semaglutide via licensed telehealth runs about $99–$300/month (the low end is a 12-month plan billed upfront) and is not FDA-approved as a finished drug. Prices are estimates as of September 2026 and change without notice.